Squarepoint Ops »

Neurogene shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-12-31 $399k 17k 22.86
2024-09-30 $209k 5.0k 41.96

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)

View all positions for Squarepoint Ops

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene